The Global Drug of Abuse Testing Market Size accounted for USD 6.7 Billion in 2022 and is projected to achieve a market size of USD 12.2 Billion by 2032 growing at a CAGR of 6.3% from 2023 to 2032.
Drug of Abuse Testing Market Report Key Highlights
- Global drug of abuse testing market revenue is expected to increase by USD 12.2 Billion by 2032, with a 6.3% CAGR from 2023 to 2032
- North America region led with more than 38% of drug of abuse testing market share in 2022
- Asia-Pacific drug of abuse testing market growth will record a CAGR of over 7% from 2023 to 2032
- According to the National Survey on Drug Use and Health, an estimated 12.8 million people aged 12 and up used illicit drugs in the previous month in the United States in 2020
- According to a 2020 Society for Human Resource Management survey, 84% of employers in the United States conduct pre-employment drug testing for some or all job candidates
- According to Quest Diagnostics' 2020 report, the overall positivity rate for workplace drug testing increased for the first time in three years, rising to 4.5% in 2019 from 4.4% in 2018
- Increasing demand for comfort and safety features in vehicles, drives the drug of abuse testing market size
Drug of abuse testing is necessary to identify the presence of different drugs in a person’s body through various samples such as urine, saliva, blood, hair, etc. Drug of abuse testing is important in order to offer appropriate medical treatment to the person or to screen or monitor for the use of illegal drugs. Some of the commonly monitored drugs include:
- Marijuana
- Methadone
- Amphetamine and methamphetamine
- Benzodiazepines such as diazepam, lorazepam and oxazepam
- Cocaine
- Barbiturates such as phenobarbital, secobarbital and pentobarbital
- Opiates, such as heroin, codeine and morphine
- Phencyclidine (PCP)
Drug of abuse testing can be performed for various reasons such as medical screening, athletics testing, employment drug testing, and legal or forensic information among others. Medical screening for drugs is performed to determine what combination of drugs a person may have consumed in order to offer appropriate treatment. The effectiveness of the drug depends on the response of the patient’s body to the substance, quantity and combination of drug consumed, and the time it was taken. Drug of abuse testing for legal purposes aims at detecting the presence of the illegitimate drug in a variety of situations. The sample collection procedures for this kind of testing are strictly controlled and documented to maintain a legal chain of custody. Drug abuse testing at the organizational level is a specific type of forensic testing. It could be done prior to the employment, or on a random basis, following an accident, or in case if the employer has reasonable suspicion over an employee using illegal drugs. Drug testing is commonly performed on athletes on national and international levels with the primary focus being on doping. The use of some banned supplements or drugs promotes muscle growth and improves strength and endurance. Organizations such as the World Anti-Doping Agency (WADA), the International Association of Athletics Federations (IAAF), and the U.S. Anti-Doping Agency (USADA) focus on monitoring and screening athletes at national, international, and Olympic levels for doping. Most substances are barred in any quantity, and some, such as caffeine, are barred only when present in large amounts. Some compounds, such as peptide hormones such as growth hormone, erythropoietin, insulin-like growth factor-1, and testosterone are banned but are hard to measure as the body also produces them naturally.
The drug abuse testing market has been growing steadily over the past few years due to a number of factors. One major factor is the increasing prevalence of drug abuse across the world, particularly in the United States. The opioid epidemic, in particular, has driven demand for drug abuse testing, as healthcare providers and employers seek to identify and treat individuals who may be at risk of addiction or overdose. Another factor driving the growth of the drug abuse testing market is the increasing availability of drug testing products and services. There is now a wide range of drug testing products on the market, including urine, blood, and hair tests, as well as more advanced tests that can detect drugs in saliva and sweat. Additionally, there are now many companies offering drug testing services, which has made drug testing more accessible and affordable for a wider range of organizations and individuals.
Global Drug of Abuse Testing Market Trends
Market Drivers
- Increasing prevalence of drug abuse
- Growing demand for drug testing in healthcare and workplace settings
- Advancements in drug testing technology and increased availability of testing products
- Stringent regulations regarding drug testing in certain industries
- Increased awareness about the harmful effects of drug abuse
Market Restraints
- High cost associated with drug testing
- Complexity of drug testing procedures and interpretation of results
Market Opportunities
- Growing trend of at-home drug testing kits and services
- Increasing focus on personalized medicine and drug monitoring
Drug of Abuse Testing Market Report Coverage
Market |
Drug of Abuse Testing Market |
Drug of Abuse Testing Market Size 2022 |
USD 6.7 Billion |
Drug of Abuse Testing Market Forecast 2032 |
USD 12.2 Billion |
Drug of Abuse Testing Market CAGR During 2023 - 2032 |
6.3% |
Drug of Abuse Testing Market Analysis Period |
2020 - 2032 |
Drug of Abuse Testing Market Base Year |
2022 |
Drug of Abuse Testing Market Forecast Data |
2023 - 2032 |
Segments Covered |
By Drug Type, By Product, By Sample Type, By End User, And By Geography
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled |
Abbott Laboratories, Danaher Corporation, Cordant Health Solutions, LabCorp, Legacy Medical Services, Quest Diagnostics, Inc., LGC Group, DrugScan, Mayo Clinic Laboratories, and Precision Diagnostics.
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Drug of Abuse Testing Market Dynamics
The global drug of abuse testing market is growing at a significant pace owing to the increased usage of drug of abuse testing at organizational levels and increased production and trade of illicit drugs worldwide. In addition, global increase in road accidents and death rates, increase in the consumption of illegal drugs and technological advancements in drug of abuse testing further drives the market growth. At the organizational level, drug of abuse testing is performed in order to increase productivity, reduce absenteeism, and improve safety. According to a report from Substance Abuse and Mental Health Services Administration (SAMHSA), between 2008 and 2012, maximum illicit drug use was found in the accommodations and food services industry, approximately 19.1% of full-time workers aged 18 years to 64 years were reported to have used illicit drugs in a time span of 30 days. Similarly, in 2015, maximum alcohol abuse was found in the mining industry, approximately 17.5% of full-time workers aged 18 years to 64 years were reported to have heavy alcohol drinking in a time span of 30 days. The increased utilization of drug of abuse testing at organizational levels is expected to drive the growth of the market in the coming years. Further, the increased production and trafficking of illegal drugs are expected to increase the demand for drug of abuse testing. According to UN Office on Drugs and Crime (UNODC), the area under opium cultivation increased from approximately 209,000 hectares in 2013 to 224,000 hectares in 2014, which is approximately a 7% increase. The extent of drug seizure can be used as an indirect measure of the increased trade of illicit drugs worldwide. For instance, according to UNODC, since 2002 Afghanistan, Iran, and Pakistan have accounted for more than 90% of opium seized across the globe, and this pattern also continued in 2013. Approximately 40 tons of cocaine was seized in 2013 in Brazil. The increase in the production and trade of illicit drugs across the globe leads to increased demand for drug of abuse testing.
Drug of Abuse Testing Market Segmentation
The global drug of abuse testing market segmentation is based on drug type, product, sample type, end user, and geography.
Drug of Abuse Testing Market By Drug Type
- Alcohol
- LSD
- Cocaine
- Opioids
- Marijuana/Cannabis
- Others
According to our drug of abuse testing industry analysis, the marijuana/cannabis segment held the largest market share in 2022. marijuana/cannabis segment is a significant component of the drug abuse testing market. Marijuana is one of the most commonly used drugs in the world and its use is becoming increasingly widespread due to its legalization for medical and/or recreational purposes in many countries and states. This has led to a growing demand for drug testing products that can accurately detect the presence of THC, the psychoactive component of marijuana, in a person's system.
Drug of Abuse Testing Market By Product
- Equipment
- Immunoassay Analyzers
- Breath Analyzers
- Chromatography Instruments
- Consumables
- Reagents
- Rapid Test Kits
- Others
In terms of products, the consumables segment is predicted to grow significantly in the coming years. Consumables are products that are used during the testing process and are consumed or disposed of after each use, such as drug testing kits, reagents, sample cups, and controls. These products are essential for accurate and reliable drug testing results and are used in a wide range of settings, including healthcare, the workplace, and criminal justice. Moreover, the consumer product segment is driven by several factors, including the increasing prevalence of drug abuse, the growing demand for drug testing products, and the increasing availability of drug testing services. In addition, the development of new and more accurate drug testing technologies is driving demand for new and innovative consumer products that can improve the accuracy, efficiency, and convenience of drug testing.
Drug of Abuse Testing Market By Sample Type
- Urine
- Breath
- Saliva
- Blood
- Hair
- Others
According to the drug of abuse testing market forecast, the urine segment is expected to witness a considerable growth rate in the coming years. urine segment is expected to continue to grow as drug abuse remains a major public health concern and the demand for drug testing products and services increases. Technological advancements and innovations in urine testing are also likely to drive growth in the segment, as new and more accurate testing methods are developed.
Drug of Abuse Testing Market By End User
- Hospitals
- Workplaces
- Research Labs
- Criminal Justice Systems
In terms of end users, the workplaces segment dominates the drug of abuse testing market in 2022. The workplace segment is a significant component of the drug of abuse testing market, as drug testing is commonly used in workplaces to ensure employee safety and productivity. Drug use in the workplace can lead to accidents, injuries, and reduced productivity, and can also have legal and financial consequences for employers. As a result, many employers have implemented drug testing programs as part of their employee screening and safety protocols. The workplace segment is driven by several factors, including regulatory requirements, the desire to promote employee safety and productivity, and the availability of affordable and accurate drug testing products. In addition, the increasing prevalence of drug abuse in society is driving demand for workplace drug testing programs.
Drug of Abuse Testing Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Drug of Abuse Testing Market Regional Analysis
North America dominates the drug of abuse testing market due to several key factors. One of the primary drivers of growth in this region is the high prevalence of drug abuse, particularly in the United States. According to the National Survey on Drug Use and Health, approximately 19.4 million adults in the United States had a substance use disorder in 2018, which represents nearly 8% of the adult population. This high prevalence of drug abuse has led to significant demand for drug testing products and services in North America.
In addition to the high prevalence of drug abuse, North America has a well-established healthcare infrastructure and a highly regulated drug testing market. The use of drug testing in the workplace and criminal justice system is also widespread in North America, further driving demand for drug testing products and services. Additionally, the presence of several key market players in North America has contributed to the region's dominance in the drug of abuse testing market. These market players have established strong distribution networks, and their products are widely used in healthcare and other settings throughout the region.
Drug of Abuse Testing Market Player
Some of the top drug of abuse testing market companies offered in the professional report include Abbott Laboratories, Danaher Corporation, Cordant Health Solutions, LabCorp, Legacy Medical Services, Quest Diagnostics, Inc., LGC Group, DrugScan, Mayo Clinic Laboratories, and Precision Diagnostics.
CHAPTER 1. Industry Overview of Drug of Abuse Testing Market
1.1. Definition and Scope
1.1.1. Definition of Drug of Abuse Testing
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Drug of Abuse Testing Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Drug of Abuse Testing Market By Drug Type
1.2.3. Drug of Abuse Testing Market By Product
1.2.4. Drug of Abuse Testing Market By Sample Type
1.2.5. Drug of Abuse Testing Market By End User
1.2.6. Drug of Abuse Testing Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Sample Type
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Drug of Abuse Testing Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Drug of Abuse Testing Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Materials
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Drug of Abuse Testing Market By Drug Type
5.1. Introduction
5.2. Drug of Abuse Testing Revenue By Drug Type
5.2.1. Drug of Abuse Testing Revenue (USD Billion) and Forecast, By Drug Type, 2020-2032
5.2.2. Alcohol
5.2.2.1. Alcohol Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. LSD
5.2.3.1. LSD Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Cocaine
5.2.4.1. Cocaine Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Opioids
5.2.5.1. Opioids Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.6. Marijuana/Cannabis
5.2.6.1. Marijuana/Cannabis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.7. Others
5.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Drug of Abuse Testing Market By Product
6.1. Introduction
6.2. Drug of Abuse Testing Revenue By Product
6.2.1. Drug of Abuse Testing Revenue (USD Billion) and Forecast, By Product, 2020-2032
6.2.2. Equipment
6.2.2.1. Equipment Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.2. Immunoassay Analyzers
6.2.2.2.1. Immunoassay Analyzers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.3. Breath Analyzers
6.2.2.3.1. Breath Analyzers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.4. Chromatography Instruments
6.2.2.4.1. Chromatography Instruments Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Consumables
6.2.3.1. Consumables Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.2. Reagents
6.2.3.2.1. Reagents Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.3. Rapid Test Kits
6.2.3.3.1. Rapid Test Kits Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.4. Others
6.2.3.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Drug of Abuse Testing Market By Sample Type
7.1. Introduction
7.2. Drug of Abuse Testing Revenue By Sample Type
7.2.1. Drug of Abuse Testing Revenue (USD Billion) and Forecast, By Sample Type, 2020-2032
7.2.2. Urine
7.2.2.1. Urine Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Breath
7.2.3.1. Breath Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Saliva
7.2.4.1. Saliva Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.5. Blood
7.2.5.1. Blood Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.6. Hair
7.2.6.1. Hair Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.7. Others
7.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Drug of Abuse Testing Market By End User
8.1. Introduction
8.2. Drug of Abuse Testing Revenue By End User
8.2.1. Drug of Abuse Testing Revenue (USD Billion) and Forecast, By End User, 2020-2032
8.2.2. Hospitals
8.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Workplaces
8.2.3.1. Workplaces Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.4. Research Labs
8.2.4.1. Research Labs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.5. Criminal Justice Systems
8.2.5.1. Criminal Justice Systems Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Drug of Abuse Testing Market By Country
9.1. North America Drug of Abuse Testing Market Overview
9.2. U.S.
9.2.1. U.S. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
9.2.2. U.S. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
9.2.3. U.S. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
9.2.4. U.S. Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
9.3. Canada
9.3.1. Canada Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
9.3.2. Canada Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
9.3.3. Canada Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
9.3.4. Canada Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Drug of Abuse Testing Market By Country
10.1. Europe Drug of Abuse Testing Market Overview
10.2. U.K.
10.2.1. U.K. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
10.2.2. U.K. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
10.2.3. U.K. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
10.2.4. U.K. Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
10.3. Germany
10.3.1. Germany Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
10.3.2. Germany Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
10.3.3. Germany Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
10.3.4. Germany Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
10.4. France
10.4.1. France Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
10.4.2. France Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
10.4.3. France Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
10.4.4. France Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
10.5. Spain
10.5.1. Spain Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
10.5.2. Spain Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
10.5.3. Spain Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
10.5.4. Spain Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
10.6.2. Rest of Europe Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
10.6.3. Rest of Europe Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
10.6.4. Rest of Europe Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Drug of Abuse Testing Market By Country
11.1. Asia Pacific Drug of Abuse Testing Market Overview
11.2. China
11.2.1. China Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
11.2.2. China Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
11.2.3. China Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
11.2.4. China Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
11.3. Japan
11.3.1. Japan Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
11.3.2. Japan Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
11.3.3. Japan Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
11.3.4. Japan Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
11.4. India
11.4.1. India Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
11.4.2. India Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
11.4.3. India Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
11.4.4. India Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
11.5. Australia
11.5.1. Australia Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
11.5.2. Australia Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
11.5.3. Australia Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
11.5.4. Australia Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
11.6. South Korea
11.6.1. South Korea Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
11.6.2. South Korea Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
11.6.3. South Korea Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
11.6.4. South Korea Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
11.7.2. Rest of Asia-Pacific Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
11.7.3. Rest of Asia-Pacific Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
11.7.4. Rest of Asia-Pacific Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Drug of Abuse Testing Market By Country
12.1. Latin America Drug of Abuse Testing Market Overview
12.2. Brazil
12.2.1. Brazil Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
12.2.2. Brazil Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
12.2.3. Brazil Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
12.2.4. Brazil Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
12.3. Mexico
12.3.1. Mexico Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
12.3.2. Mexico Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
12.3.3. Mexico Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
12.3.4. Mexico Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
12.4.2. Rest of Latin America Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
12.4.3. Rest of Latin America Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
12.4.4. Rest of Latin America Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Drug of Abuse Testing Market By Country
13.1. Middle East & Africa Drug of Abuse Testing Market Overview
13.2. GCC
13.2.1. GCC Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
13.2.2. GCC Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
13.2.3. GCC Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
13.2.4. GCC Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
13.3. South Africa
13.3.1. South Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
13.3.2. South Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
13.3.3. South Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
13.3.4. South Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032
13.4.2. Rest of Middle East & Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
13.4.3. Rest of Middle East & Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032
13.4.4. Rest of Middle East & Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Drug of Abuse Testing Market
14.1. Drug of Abuse Testing Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Drug of Abuse Testing Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Abbott Laboratories
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2022
15.1.3.2. Abbott Laboratories 2022 Drug of Abuse Testing Business Regional Distribution
15.1.4. Product /Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Danaher Corporation
15.3. Cordant Health Solutions
15.4. LabCorp
15.5. Legacy Medical Services
15.6. Quest Diagnostics, Inc.
15.7. LGC Group
15.8. DrugScan
15.9. Mayo Clinic Laboratories
15.10. Precision Diagnostics